WHO releases new guidelines on hepatitis B
In a landmark move, the World Health Organization (WHO) has released groundbreaking guidelines to address the global challenge of chronic hepatitis B (HBV) infection.
Unveiled at the 2024 Asian Pacific Conference for the Study of Liver Disease in Kyoto, Japan, these guidelines aim to simplify and expand access to HBV testing and treatment, marking a crucial step towards the WHO's goal of eliminating viral hepatitis by 2030. With over 250 million people worldwide living with HBV, the new WHO guidelines focus on preventing mother-to-child transmission, a key transmission route, by recommending antiviral treatment for pregnant women and immediate newborn vaccination. This approach not only aims to reduce the global burden of HBV but also prevents liver-related complications, aligning with India's efforts to curb the disease through its Universal Immunization Program (UIP).
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.